Paul Hartmann AGFRA:PHH2 +1.49%61 Days Inventory is 192.07 as of Dec. 2025, which is 32% above its 10-year median of 145.30. GuruFocus rates FRA:PHH2 with a GF Score™ of 61/100 and a GF Value™ of €226.41 (Fairly Valued). The stock has 4 warning signs investors should review. Among 784 Medical Devices & Instruments companies, Paul Hartmann AG ranks worse than 55.61% on this metric.
The historical rank and industry rank for Paul Hartmann AG's Days Inventory or its related term are showing as below:
FRA:PHH2'
s Days Inventory Range Over the Past 10 Years
Min: 124.32 Med: 145.3 Max: 192.96
Current: 192.96
During the past 13 years, Paul Hartmann AG's highest Days Inventory was 192.96. The lowest was 124.32. And the median was 145.30.
FRA:PHH2's Days Inventory is ranked worse than 55.61% of 784
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs FRA:PHH2: 192.96
Paul Hartmann AG's Days Inventory
increased
from Dec. 2024 (180.87) to Dec. 2025 (192.07).
It might indicate that Paul Hartmann AG's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Paul Hartmann AG's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.95.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Paul Hartmann AG's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.42.
Paul Hartmann AG (FRA:PHH2) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Paul Hartmann AG's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Paul Hartmann AG's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Paul Hartmann AG Days Inventory Related Terms
Paul Hartmann AG Days Inventory Historical Data
* Premium members only.
The historical data trend for Paul Hartmann AG's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PHH2 vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paul Hartmann AG Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's Days Inventory distribution charts can be found below:
* The bar in red indicates where Paul Hartmann AG's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paul Hartmann AG (FRA:PHH2) has a Days Inventory of 192.07 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Paul Hartmann AG and its competitors. This is 32% above median its historical median of 145.30. Over the past decade, Paul Hartmann AG's Days Inventory has ranged from 124.32 to 192.96. According to the industry distribution chart, Paul Hartmann AG ranks #436 out of 784 companies in the Medical Devices & Instruments industry, placing it in the top 55.6%.
Is Paul Hartmann AG's Days Inventory too high?
Paul Hartmann AG's current Days Inventory of 192.07 is 32% above median its 10-year median of 145.30. Over the past 10 years, this metric has ranged from a low of 124.32 to a high of 192.96. The Medical Devices & Instruments industry median Days Inventory is 179.12. Paul Hartmann AG's value of 192.07 is 7.2% above this industry median. Based on the distribution chart, Paul Hartmann AG ranks #436 out of 784 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Paul Hartmann AG has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Paul Hartmann AG's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Paul Hartmann AG ranks #436 out of 784 companies for Days Inventory. This places Paul Hartmann AG in the lower half of its industry. The industry median Days Inventory is 179.12. Paul Hartmann AG's value of 192.07 is 7.2% above this benchmark. Historically, Paul Hartmann AG's own Days Inventory has ranged from 124.32 to 192.96 over the past decade. While the company's 10-year median is 145.30 vs. the industry median of 179.12, Paul Hartmann AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paul Hartmann AG's current Days Inventory of 192.07 is 7.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Paul Hartmann AG and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paul Hartmann AG's current Days Inventory is 192.07, which is 32% above median its own 10-year median of 145.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paul Hartmann AG stock overvalued right now?
Based on GuruFocus' analysis, Paul Hartmann AG (FRA:PHH2) is currently considered Fairly Valued. The stock's GF Value™ is €226.41, compared to a current price of €205.00 — trading 9.5% below its estimated fair value. The current Days Inventory is 192.07, which is 32% above median its 10-year median of 145.30 and 7.2% above the Medical Devices & Instruments industry median of 179.12. Paul Hartmann AG's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Paul Hartmann AG (FRA:PHH2), the current Days Inventory is 192.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paul Hartmann AG (FRA:PHH2) Overvalued in 2026?
Based on GuruFocus' analysis, Paul Hartmann AG stock appears to be undervalued.
The current stock price of €205.00 is trading 9.5% below its estimated GF Value™ of €226.41.
GuruFocus considers Paul Hartmann AG to be Fairly Valued.
Key valuation signals for FRA:PHH2:
Days Inventory: 192.07 (32% above median its 10-year median of 145.30)
GF Value™: €226.41 vs. price of €205.00 (9.5% below fair value)
Industry Position: 7.2% above the Medical Devices & Instruments median (#436 of 784)
No single metric tells the full story. See the FRA:PHH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
61GF Score
Get the complete analysis for FRA:PHH2
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PHH2 has been successfully added to your 
